Immuneering Strengthens Executive Team With Appointment of Howard L. Kaufman, M.D., as Head of Research and Development CAMBRIDGE, Mass., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Immuneering Corporation today announced an addition to its executive leadership team with the appointment of Howard L. Kaufman, M.D., FACS, as...

Immuneering Appoints Scott Barrett, M.D., as Chief Medical Officer CAMBRIDGE, Mass., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Immuneering Corporation today announced the appointment of Scott Barrett, M.D., as chief medical officer. Dr. Barrett brings nearly three decades...

Immuneering Completes $17 Million Series A Financing CAMBRIDGE, Mass., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Immuneering Corporation today announced the completion of a $17 million Series A financing. The financing was led by Boxcar PMJ LLC. Concurrent...

Immuneering to Present at the 12th International Conference on Cachexia, Sarcopenia & Muscle Wasting CAMBRIDGE, Mass., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Immuneering today announced the company’s participation in the 12th International Conference on Cachexia, Sarcopenia & Muscle Wasting taking...